Summary:
- The U.S. Food and Drug Administration (FDA) is facing significant layoffs in its Center for Devices and Radiological Health (CDRH), which is responsible for regulating medical devices, including those that use artificial intelligence (AI).
- The layoffs could impact the CDRH's ability to keep up with the rapid pace of innovation in the medical device industry, particularly in the field of AI-powered devices.
- The article suggests that the layoffs could slow down the FDA's review and approval process for new medical devices, potentially delaying the availability of innovative technologies for patients.